Cargando…
Update on vaccine development for renal cell cancer
Renal cell carcinoma (RCC) remains a significant health concern that frequently presents as metastatic disease at the time of initial diagnosis. Current first-line therapeutics for the advanced-stage RCC include antiangiogenic drugs that have yielded high rates of objective clinical response; howeve...
Autores principales: | Chi, Nina, Maranchie, Jodi K, Appleman, Leonard J, Storkus, Walter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703676/ https://www.ncbi.nlm.nih.gov/pubmed/24198621 |
Ejemplares similares
-
Renal Medullary Carcinoma: Case Report of an Aggressive Malignancy with Near-Complete Response to Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy
por: Amjad, Ali Imran, et al.
Publicado: (2014) -
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
por: Filderman, Jessica N., et al.
Publicado: (2021) -
Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022) -
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation
por: Nguyen, Nghi C., et al.
Publicado: (2016) -
Update on Campylobacter vaccine development
por: Poly, Frédéric, et al.
Publicado: (2018)